Xiaomeng Li
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 14
- MicroRNA in disease regulation 10
- Toxicology top 2%
- Pharmacology top 1%
- Molecular Biology top 5%
- Natural product bioactivities and synthesis 14
- Cancer-related gene regulation 9
- Ubiquitin and proteasome pathways 8
-
- Prostate Cancer Treatment and Research 16
-
- Covalent Organic Framework Applications 11
-
- Metal-Organic Frameworks: Synthesis and Applications 10
- Co-authors
- Jiang LiAzhar RasulFaya Martin MillimounoMuhammad AliZijie SunGhulam HussainWafa Ali EltaybWei Wei
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Xiaomeng Li
240 papers receiving 4.8k citations
Peers
Comparison fields: 5 of 166
- Cancer Research 611
- Toxicology 121
- Complementary and alternative medicine 285
- Pharmacology 265
- Molecular Biology 2.0k
Countries citing papers authored by Xiaomeng Li
This map shows the geographic impact of Xiaomeng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaomeng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaomeng Li more than expected).
Fields of papers citing papers by Xiaomeng Li
This network shows the impact of papers produced by Xiaomeng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaomeng Li. The network helps show where Xiaomeng Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiaomeng Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 4 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 1 | |
| 5 | 2025 | 0 | |
| 6 | 2024 | 15 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 1 | |
| 9 | 2024 | 1 | |
| 10 | 2024 | 28 | |
| 11 | 2024 | 2 | |
| 12 | 2023 | 1 | |
| 13 | 2023 | 0 | |
| 14 | 2023 | 11 | |
| 15 | 2023 | 3 | |
| 16 | 2023 | 1 | |
| 17 | 2022 | 5 | |
| 18 | 2020 | 32 | |
| 19 | 2020 | 9 | |
| 20 | Dracorhodin perchlorate induces apoptosis in bladder cancer cells through Bcl-2, Bcl-XL, survivin down-regulation and caspase-3 activation | 2013 | 0 |
About Xiaomeng Li
Xiaomeng Li is a scholar working on Toxicology, Cancer Research and Molecular Biology, having authored 255 papers that have together received 4.8k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (16 papers), Natural product bioactivities and synthesis (14 papers), Cancer-related molecular mechanisms research (14 papers), Covalent Organic Framework Applications (11 papers), MicroRNA in disease regulation (10 papers), Metal-Organic Frameworks: Synthesis and Applications (10 papers), Cancer-related gene regulation (9 papers) and Ubiquitin and proteasome pathways (8 papers). The work is most often cited by research in Cancer Research (611 citations), Toxicology (121 citations) and Complementary and alternative medicine (285 citations). Xiaomeng Li has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Jiang Li, Azhar Rasul, Faya Martin Millimouno, Muhammad Ali, Zijie Sun, Ghulam Hussain, Wafa Ali Eltayb, Wei Wei, Yang Liu and Haseeb Anwar. Their work appears in journals such as Frontiers in Immunology, Molecules, Scientific Reports, Angewandte Chemie International Edition and BioMed Research International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.